Comprehensive csl behring operations including research, development, and commercialization activities. This segment focuses on innovative approaches and solutions within the csl behring field, leveraging advanced technologies and expertise to address unmet medical needs and improve patient outcomes.

Manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products.